Latest news from Sexton Biotechnologies on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/sexton-biotechnologies-partners-with-biospherix-to-create-a-fully-enclosed-modular-fill-finish-system-with-rapid-deployment-for-emerging-cell-and-gene-therapy-needs/?sc=rsin /articles/sexton-biotechnologies-partners-with-biospherix-to-create-a-fully-enclosed-modular-fill-finish-system-with-rapid-deployment-for-emerging-cell-and-gene-therapy-needs/?sc=rsin Thu, 11 Jun 2020 13:05:37 EST Sexton Biotechnologies has announced a new collaboration with BioSpherix Medical. As a tool and technologies partners of the Cell and Gene industry, Sexton and BioSpherix both recognize the need for cost-effective and flexible automation solutions during cell and gene therapy process development. Sexton Biotechnologies /articles/sexton-biotechnologies-and-ikeda-scientific-provide-human-platelet-lysate-to-japanese-regenerative-medicine-product-manufacturers/?sc=rsin /articles/sexton-biotechnologies-and-ikeda-scientific-provide-human-platelet-lysate-to-japanese-regenerative-medicine-product-manufacturers/?sc=rsin Tue, 26 May 2020 08:55:01 EST Sexton Biotechnologies pathogen reduced hPL confirmed by PMDA as human derived raw material for regen med products. Sexton Biotechnologies